Almac Group, the global contract development and manufacturing organisation is delighted to announce that its temperature management software solution, TempEZ™, has received the award for Innovation from IT services company, Version 1, during their ‘Evolving the Digital Enterprise Expo’ at the Royal College of Physicians, Dublin, Ireland
Judges selected the TempEZ™ offering based on three key criteria - excellence and innovation in delivery of Almac's temperature management solution; the scale and complexity of the environment in which the project was executed and the tangible evidence of enhancing Almac's business. The coveted award was accepted by Julie Shannon, Almac Group's IS Support Manager during the event.
Almac's TempEZ™ solution was showcased at the 14th IQPC Cold Chain GDP & Temperature Management Logistics Global Forum in Boston on 26th September 2016. The innovative service offers clients a single database to store temperature data from manufacture of product right through to patient administration and assists with GDP and GMP regulatory compliance. The platform provides clients with the ability to record planned and unplanned excursions for pharmaceutical products and build a complete temperature history at either a batch or serialised level. The system is monitor, logistics provider and Interactive Response Technology (IRT) vendor agnostic, allowing clients flexibility in managing their supply chain. .
Donna Christopher, Global VP of Operations, Almac Clinical Services expressed her delight with the award stating:
This is worthy recognition of a market leading temperature management solution and also the years of work that our team has dedicated to developing this innovative product for our customers. We developed TempEZ™ from a pharmaceutical perspective, directly leveraging our experience of packaging, storing and distributing medical products; 2.5 million shipments over the last decade alone. We are confident that the launch of this software marks a turning point in the management of global temperature controlled logistics.
About Almac Group
'Partnering to Advance Human Health'
The Almac Group is an established contract development and manufacturing organisation that provides an extensive range of integrated services to the pharmaceutical and biotech sectors globally. The services range from R&D, biomarker discovery development and commercialisation, API manufacture, formulation development, clinical trial supply, IXRS® technology (IVRS/IWRS) through to commercial-scale manufacture.
The international company is a privately owned organisation that has organically grown over 40 years and now employs in excess of 4,500 highly skilled personnel. Almac is headquartered in Craigavon, Northern Ireland with operations in the UK, Ireland, across the US (Pennsylvania, North Carolina and California) and in Asia (Singapore and Tokyo).